UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression

Cell stem cell, 2014-06, Vol.14 (6), p.810-823

2014

Volltextzugriff (PDF)

A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan

Cell metabolism, 2015-07, Vol.22 (1), p.86-99

2015

Volltextzugriff (PDF)

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

The lancet oncology, 2016-09, Vol.17 (9), p.1317-1324

2016

Volltextzugriff (PDF)

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

BMC cancer, 2018-04, Vol.18 (1), p.368-15, Article 368

2018

Volltextzugriff (PDF)

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma

Cancers, 2021-02, Vol.13 (4), p.889

2021

Volltextzugriff (PDF)

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer

Asian journal of andrology, 2018-05, Vol.20 (3), p.215-220

2018

Volltextzugriff (PDF)

Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review

Cancers, 2022-10, Vol.14 (20), p.5149

2022

Volltextzugriff (PDF)

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231170474-17588359231170474

2023

Volltextzugriff (PDF)

Factors influencing post‐recurrence survival in bladder cancer following radical cystectomy

BJU international, 2012-03, Vol.109 (6), p.846-854

2012

Volltextzugriff (PDF)

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004400

2022

Volltextzugriff (PDF)

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer

Clinical nuclear medicine, 2012-07, Vol.37 (7), p.637-643

2012

Volltextzugriff (PDF)

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients

Urologic oncology, 2014, Vol.32 (1), p.52.e1-52.e9

2014

Volltextzugriff (PDF)

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2040-2045

2011

Volltextzugriff (PDF)

Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients

Clinical chemistry (Baltimore, Md.), 2009-03, Vol.55 (3), p.559-567

2009

Volltextzugriff (PDF)

Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial

Integrative cancer therapies, 2021, Vol.20, p.15347354211035442-15347354211035442

2021

Volltextzugriff (PDF)

A Path to Precision Medicine in Prostate Cancer: Learning from “Negative” Trials of Targeted Therapies

European urology, 2022-11, Vol.82 (5), p.516-517

2022

Volltextzugriff (PDF)

Recent developments in the treatment of non-metastatic castration resistant prostate cancer

Cancer treatment and research communications, 2020, Vol.24, p.100181-100181, Article 100181

2020

Volltextzugriff (PDF)

A Phase II trial of AEZS-108 in Castration and Taxane Resistant Prostate Cancer

Clinical genitourinary cancer, 2017-12, Vol.15 (6), p.742-749

2017

Volltextzugriff (PDF)

Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2018-10, Vol.68 (4), p.1412-1428

2018

Volltextzugriff (PDF)

Safety and feasibility of fasting in combination with platinum-based chemotherapy

BMC cancer, 2016-06, Vol.16 (1), p.360, Article 360

2016

Volltextzugriff (PDF)

PROTACing the androgen receptor and other emerging therapeutics in prostate cancer

Expert review of anticancer therapy, 2024-09, Vol.24 (9), p.829-835

2024

Volltextzugriff (PDF)

Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer

Clinical cancer research, 2022-02, Vol.28 (4), p.576-584

2022

Volltextzugriff (PDF)

Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

The lancet oncology, 2022-07, Vol.23 (7), p.899-909

2022

Volltextzugriff (PDF)

Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity

Molecular therapy, 2021-07, Vol.29 (7), p.2335-2349

2021

Volltextzugriff (PDF)

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients

Translational andrology and urology, 2021-07, Vol.10 (7), p.3199-3207

2021

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Englisch
(293)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(137)
Clinical Genitourinary Cancer
(16)
Clinical Cancer Research
(10)
Cancer Research
(8)
Therapeutic Advances In Medical Oncology
(5)
Urology
(5)
Bju International
(4)
Cancer
(4)
Cancers
(4)
Nature Medicine
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression

A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer

Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review

Factors influencing post‐recurrence survival in bladder cancer following radical cystectomy

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients

Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial

A Path to Precision Medicine in Prostate Cancer: Learning from “Negative” Trials of Targeted Therapies

Recent developments in the treatment of non-metastatic castration resistant prostate cancer

A Phase II trial of AEZS-108 in Castration and Taxane Resistant Prostate Cancer

Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma

Safety and feasibility of fasting in combination with platinum-based chemotherapy

PROTACing the androgen receptor and other emerging therapeutics in prostate cancer

Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer

Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients

Suchergebnisse filtern